Combine patient voice and
clinical insights to elevate the
full value of your treatment
Clinical trial data uncovers multiple stories. So why listen to just one?
One2Treat is dedicated to transforming the way biopharmaceutical companies design and evaluate clinical trials, and how the overall medical value of a treatment may be communicated, by integrating multiple meaningful dimensions in the treatment assessment.
Including multiple criteria within a single primary endpoint, our approach:
- allows to capture and prioritize input from patients, clinicians, regulatory bodies and clinical trial sponsors,
- reduces sample sizes in clinical trials, cutting clinical research timelines
- connects the dots from R&D to market access
An already approved approach in multiple therapeutic areas, One2Treat’s solution ensures the medical need and potential of every product is explored in full. It showcases valuable additional treatment benefits to help strengthen both regulatory submission and post-regulatory market access.
Experience how our solution can revolutionize the holistic statistical assessment of your treatment.
Innovative Trial Design
Know more with less. Integrate multiple clinically relevant outcomes in your primary analysis to better leverage your data and reduce the sample size required to assess the Net Treatment Benefit.
One2Treat Voice helps identify and prioritize these outcomes based on patient or clinician input.
Strategic Decisions Across Clinical Development
Assess the totality of evidence and understand the full medical value of your treatment.
One2Treat Insights supports dose selection and go/no-go decisions, driving more relevant, efficient, and patient-centered trials.
Benefit-Risk Assessment
Leverage quantitative evaluations for evidence-based Health Technology Assessment (HTA) and Health Economics and Outcomes Research (HEOR), strengthening your market access strategy and commercial messaging.
OUR LATEST RESOURCES
